Matters of legal in nature including licensing, intellectual property, and lawsuits.
MilliporeSigma Receives Patent for CRISPR Technology in China Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells Company to license CRISPR-related patents to interested parties, supports genome-editing research under ethical and legal standards Foundational CRISPR patents now granted in seven markets, including Canada and Europe Burlington, Massachusetts, April... Read more
Basel, 23 April 2018 New OCREVUS (ocrelizumab) data at AAN demonstrate significant reductions in disease activity and disability progression in relapsing multiple sclerosis Four years of continuous treatment with OCREVUS showed a sustained reduction in underlying disease activity in relapsing MS (RMS) in analysis from the open-label extension period Additional analyses show OCREVUS delayed cognitive... Read more
Basel, 23 April 2018 New OCREVUS (ocrelizumab) data at AAN demonstrate significant reductions in disease activity and disability progression in relapsing multiple sclerosis Four years of continuous treatment with OCREVUS showed a sustained reduction in underlying disease activity in relapsing MS (RMS) in analysis from the open-label extension period Additional analyses show OCREVUS delayed cognitive... Read more
16. Apr, 2018 By Richard Mills, rim@foss.dk The FOSS BacSomatic™ analyser has been granted certificate of compliance for enumeration of somatic cells as well as total bacterial count in raw cow’s milk by Microval – a certification organisation of the European Union. The BacSomatic is a new analyser for rapid hygiene testing of raw milk and is the... Read more
Basel, 16 April 2018 Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline Breadth of data will reinforce efficacy and safety of OCREVUS in relapsing and primary progressive multiple sclerosis and demonstrate its benefits in slowing disability progression, including new cognitive and biomarker results Important research in Alzheimer’s... Read more
Basel, 16 April 2018 Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline Breadth of data will reinforce efficacy and safety of OCREVUS in relapsing and primary progressive multiple sclerosis and demonstrate its benefits in slowing disability progression, including new cognitive and biomarker results Important research in Alzheimer’s... Read more
NEW ORLEANS, April 13, 2018 /PRNewswire/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Illumina, Inc. (Nasdaq: ILMN). During the first two quarters of 2016, the Company, which provides genetic sequencing products to customers in the... Read more
Rapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot Release MycoSEQ Mycoplasma Detection Method can accelerate production timelines for manufacturers of cell and gene therapies, biotherapeutics, vaccines and other cell-culture-based modalities BEDFORD, Mass., April 3, 2018 /PRNewswire/ — Manufacturers of cell-culture-based therapeutics can now rely on a faster method for detecting mycoplasma contamination.... Read more